Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for PRME.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 103.51M
March 31, 2026 105.97M
December 31, 2025 108.29M
September 30, 2025 110.42M
June 30, 2025 112.48M
March 31, 2025 114.29M
December 31, 2024 37.18M
September 30, 2024 36.76M
June 30, 2024 36.37M
March 31, 2024 37.04M
December 31, 2023 4.357M
September 30, 2023 5.822M
Date Value
June 30, 2023 11.93M
March 31, 2023 14.20M
December 31, 2022 17.05M
September 30, 2022 19.86M
June 30, 2022 22.76M
March 31, 2022 2.092M
December 31, 2021 3.07M
September 30, 2021 4.267M
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. 232.15M
Twist Bioscience Corp. 84.96M
Sana Biotechnology, Inc. 59.23M
Intellia Therapeutics, Inc. 50.07M
Revolution Medicines, Inc. 1.174B